参考文献/References:
[1] Collis S J, DeWeese TL. Enhanced radiation response through directed molecular targeting approaches. Cancer Metastasis Rev, 2004, 23(3-4):277-292.
[2] Baker SJ, Markowitz S, Fearon ER, et al. Suppression of human colorectal carcinoma cell growth by wild-type p53. Science, 1990, 249(4971):912-915.
[3] Hanpt S, Haupt Y. Importance of p53 for cancer onset and therapy. Anticancer Drugs, 2006, 17(7):725-732.
[4] Mimeault M, Batra SK. Recent advances on multiple tumorigenic cascades involved in prostatic cancer progression and targeting therapies. Carcinogenesis, 2006, 27(1):1-22.
[5] Guha A, Mukherjee J. Advances in the biology of astrocytomas. Curt Opin Neurol, 2004, 17(6):655-662.
[6] 肖绍文,张珊文,吕有勇,等.外源性p53基因对人胃癌细胞的放射增敏作用.北京大学学报(医学版),2001,33(5):427-431.
[7] Moon C, Oh Y, Roth JA. Current status of gene therapy for lung cancer and head and neck cancer. Clin Cancer Res, 2003, 9(14):5055-5067.
[8] Lavin MF, Khanna KK. ATM:the protein encoded by the gene mutated in the radiosen-sitive syndrome ataxia-telangiectasia. Int J Radiat Biol, 1999, 75(10):1201-1214.
[9] Fan Z, Chakravarty P, Alfieri A, et al. Adenovirus-mediated antisense ATM gene transfer sensitizes prostate cancer cells to radiation. Cancer Gene Ther, 2000, 7(10):1307-1314.
[10] Guha C, Guha U, Tribius S, et al. Antisense ATM gene therapy:a strategy to increase the radiosensitivity of human tumors. Gene Ther, 2000, 7(10):852-858.
[11] Normanno N, Maiello MR, De Luca A. Epidermal growth factor receptor tyrosine kinase inhibitors(EGFR-TKIs):simple drugs with a complex mechanism of action?. J Cell Physiol, 2003, 194(1):13-19.
[12] Harari PM, Huang SM. Epidermal growth factor receptor modulation of radiation response:preclinical and clinical development. Semin Radiat Oncol, 2002, 12(3 Suppl 2):21-26.
[13] Harari PM, Huang SM. Radiation response modification following molecular inhibition of epidermal growth factor receptor signaling. Semin Radiat Oncol, 2001,11(4):281-289.
[14] Taira N, Doihara H, Oota T, et al. Gefitinib, an epidermal growth factor receptor blockade agent, shows additional or synergistic effects on the radiosensitivity of esophageal cancer cells in vitro. Acta Med Okayama, 2006, 60(1):25-34.
[15] Dobelbower MC, Russo SM, Raisch KP, et al. Epidermal growth factor receptor tyrosine kinase inhibitor, erlotinib, and concurrent 5-fluorouracil, cisplatin and radiotherapy for patients with esophageal cancer:a phase I study. Anticancer Drugs, 2006, 17(1):95-102.
[16] Vlachaki MT, Chhikara M, Aguilar L, et al. Enhanced therapeutic effect of multiple injections of HSV-TK +GCV gene therapy in combination with ionizing radiation in a mouse nmannary tumor model. Int J Radiat Oncol Biol Phys, 2001, 51(4):1008-1017.
[17] Chhikara M, Huang H, Vlachaki MT, et al. Enhanced therapeutic effect of HSV-tk +GCV genetherapy and ionizing radiation for prostate cancer. Mol Ther, 2001:3(4):536-542.
[18] Stackhouse MA, Pederson LC, Grizzle WE, et al. Fractionated radiation therapy in combination with adenoviral delivery of the cytosine deaminase gene and 5-fluorocytosine enhances cytotoxic and antitumor effects in human colorectal and cholangiocarcinoma models. Gene Ther, 2000, 7(12):1019-1026.
[19] Freytag SO, Strieker H, Pegg J, et al. Phase I study of replication-competent adenovirus-mediated double-suicide gene therapy in combination with conventional-dose three-dimensional conformal radiation therapy for the treatment of newly diagnosed interme-diate-to high-risk prostate cancer. Cancer Res, 2003, 63(21):7497-7506.
[20] 张燕,涂文勇.非小细胞肺癌p16基因表达与放疗敏感性的关系.临床肿瘤学杂志,2005,10(6):637-640.
[21] 伍海军,申良方,肖华平,等.增殖细胞核抗原和p16蛋白表达与鼻咽癌放射敏感性相关性研究.中国医师杂志,2007,9(5):619-621.
[22] 付艳军,刘世喜,鲜均明.外源性p16基因与放疗联合治疗喉鳞癌的实验研究.四川大学学报(医学版),2004,35(2):209-211.
[23] Han JA, Kim JI, Ongusaha PP, et al. P53-mediated induction of Gox-2 counteracts p53-or genotoxic stress-induced apoptosis. EMBO J, 2002, 21(21):5635-5644.
相似文献/References:
[1]何燕,苏晋,郑晓霞,等.P-糖蛋白抑制剂在PET显像中的应用研究[J].国际放射医学核医学杂志,2016,40(1):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
He Yan,Su Jin,ZhengXiaoxia,et al.Developing P-glycoprotein inhibitor marked by PET[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):1.[doi:10.3760/cma.j.issn.1673-4114.2016.01.001]
[2]许飞,刘建军,黄钢,等.PET乏氧显像在预测肿瘤乏氧及指导临床治疗中的应用进展[J].国际放射医学核医学杂志,2016,40(1):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
Xu Fei,Liu Jianjun,Huang Gang,et al.The application of hypoxia imaging with PET in predicting tumor hypoxia and guiding clinical therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):35.[doi:10.3760/cma.j.issn.1673-4114.2016.01.008]
[3]陈顺军,程兵.肿瘤细胞凋亡核素显像分子探针研究进展[J].国际放射医学核医学杂志,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
Chen Shunjun,Cheng Bing.Progress in molecular probes of radionuclide tumor apoptosis imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):149.[doi:10.3760/cma.j.issn.1673-4114.2016.02.013]
[4]陈晓艳,张江虹,邵春林.STAT3与辐射敏感相关性的研究进展[J].国际放射医学核医学杂志,2016,40(3):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
Chen Xiaoyan,Jianghong,Shao Chunlin.Research progresses of correlation between STAT3 and radiosensitivity[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):191.[doi:10.3760/cma.j.issn.1673-4114.2016.03.007]
[5]赵舒怡,储小飞,樊赛军.血清肿瘤标志物与肿瘤放疗疗效评估的研究进展[J].国际放射医学核医学杂志,2015,39(5):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
zhao shuyi,chu xiaofei,fan saijun..progression of study on serum tumor markers in evaluation of tumor radiotherapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):427.[doi:10. 3760 / cma. j. issn. 1673-4114. 2015. 05. 018]
[6]赵徵鑫,翟贺争,张文艺,等.质子重离子治疗肿瘤的进展[J].国际放射医学核医学杂志,2016,40(5):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
Zhao Zhixin,Zhai Hezheng,Zhang Wenyi,et al.Development of proton heavy ion in tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):384.[doi:10.3760/cma.j.issn.1673-4114.2016.05.010]
[7]任佳忠,李永梅,刘岩,等.99Tcm-MDP骨显像胸部异常放射性摄取的原因分析[J].国际放射医学核医学杂志,2016,40(6):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
Jiazhong,Li Yongmei,Liu Yan,et al.Reasons for the abnormal 99Tcm-MDP uptake in the thoracic tissue on bone scintigraphy[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):459.[doi:10.3760/cma.j.issn.1673-4114.2016.06.011]
[8]马彦云,张辉.磁共振体素内不相干运动扩散加权成像的原理及应用进展[J].国际放射医学核医学杂志,2016,40(6):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
Ma Yanyun,Zhang Hui.The basic principle and application progress of intravoxel incoherent motion imaging[J].International Journal of Radiation Medicine and Nuclear Medicine,2016,40(2):469.[doi:10.3760/cma.j.issn.1673-4114.2016.06.013]
[9]杨卫东,汪静.肿瘤核素靶向治疗新进展[J].国际放射医学核医学杂志,2015,39(1):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
Yang Weidong,Wang Jing.Advance progress of radionuclide target tumor therapy[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):19.[doi:10.3760/cma.j.issn.1673-4114.2015.01.006]
[10]徐金苹,袁德晓,张江虹,等.辐射诱导的外泌体在肿瘤细胞侵袭转移中的作用[J].国际放射医学核医学杂志,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
Xu Jinping,Yuan Dexiao,Zhang Jianghong,et al.The role of radiation-induced exosomes in tumor invasion and metastasis[J].International Journal of Radiation Medicine and Nuclear Medicine,2015,39(2):144.[doi:10.3760/cma.j.issn.1673-4114.2015.02.009]
[11]张俊,刘增礼.钠碘转运体基因介导的肿瘤放射性核素治疗研究[J].国际放射医学核医学杂志,2008,32(1):8.
ZHA NG Jun,LIU Zeng-li.Sodium iodide symporter gene-mediated radionuclide therapy of tumors[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):8.
[12]张耀文,曹永珍,李进,等.基因治疗联合放射治疗恶性肿瘤[J].国际放射医学核医学杂志,2008,32(4):247.
ZHANG Yao-wert,CAO Yong-zhen,LI Jin,et al.Gene therapy and radiotherapy in malignant tumor[J].International Journal of Radiation Medicine and Nuclear Medicine,2008,32(2):247.
[13]赵艳芝,李进,王芹,等.恶性肿瘤基因治疗和放射治疗相互作用的机制及联合治疗展望[J].国际放射医学核医学杂志,2006,30(4):250.
ZHAO Yan-zhi,LI Jin,WANG Qin,et al.The mechanisms of inter-effect about gene therapy and raidotherapy to tumor and the prospect of therapeutic alliance[J].International Journal of Radiation Medicine and Nuclear Medicine,2006,30(2):250.